Companies · Other Health Care

OB Hospitalist Group, Inc.

Mauldin · Other Health Care

Diligence memoA one-page analyst read on OB Hospitalist Group, Inc. — recommendation, valuation, rhythm, risks.
$73.8M
Total raised · real
4
Rounds
0.0×
Latest step-up
Top 6%
Sector rank · raised
Series C
Latest stage · inferred · Fri Oct 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

OB Hospitalist Group, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.01× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era.
Dormant
  • Last raise 9.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

OB Hospitalist Group, Inc. is one of 5377 Other Health Care companies tracked from Mauldin. By capital raised it ranks among the largest (ahead of 95% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2016-10-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries A · 2010-04-09 Raised $15M (real) Modeled valuation $299M (est)$15M$299MSeries A2010Series C · 2013-07-31 Raised $51M (real) Modeled valuation $1.2B (est)$51M$1.2BSeries C2013Series C · 2014-07-02 Raised $8.0M (real) Modeled valuation $183M (est)$8.0M$183MSeries C2014Series C · 2016-10-21 Raised $344K (real) Modeled valuation $7.9M (est)$344K$7.9MSeries C2016+$51M+$8.0M+$344KCumulative $74M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$14.8M · 2010
Series C$50.6M · 2013no Series B on file
Series C extension$8.0M · 2014
Series C extension$344K · 2016

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$7.9M
Base estimate est.
$1.2M
Conservative case
$20.7M
Upside case
$2.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $299.5M · 2010-04-092010Series C · modeled $1.2B · 2013-07-31Series C · modeled $182.9M · 2014-07-02Series C · modeled $7.9M · 2016-10-212016
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
6.0 yr
Elapsed time used
9.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
26 mo
Avg between rounds
$11.3M/yr
Capital velocity
16.2 yr
On record since
2010
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 30× above median
This company$73.8M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.0× of median
This company$344K
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 0.4× of median
This company$7.9M
Sector median$22.1M

Raised more than 95% of sector peers (real $). Modeled value above 30% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #40 of 40.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Specialty Networks, LLC · Series C Raised $94.5M · modeled $2.2B (est)New MMI Holdings, Inc. · Series C Raised $80.7M · modeled $1.8B (est)BioMatrix Holdings, L.L.C. · Series C Raised $80.0M · modeled $1.8B (est)Sea Hunter Holdings, LLC · Series C Raised $76.3M · modeled $1.7B (est)Bind Benefits, Inc. · Series C Raised $70.0M · modeled $1.6B (est)Endotronix Inc · Series C Raised $116.1M · modeled $1.6B (est)Great Basin Scientific, Inc. · Series C Raised $124.3M · modeled $1.6B (est)TransMedics, Inc. · Series C Raised $249.0M · modeled $1.5B (est)Landmark Health, LLC · Series C Raised $90.8M · modeled $1.4B (est)Rapid Micro Biosystems, Inc. · Series C Raised $134.6M · modeled $1.4B (est)Mdp Acm Holdings, Llc · Series C Raised $60.0M · modeled $1.4B (est)ACON BioMatrix Investors I, L.L.C. · Series C Raised $57.5M · modeled $1.3B (est)OB Hospitalist Group, Inc. (this company) Raised $73.8M · modeled $7.9M (est)OB Hospitalist Group, Inc.
CompanyStageRaised · realValue · estvs peer med.
Specialty Networks, LLCSeries C$94.5M$2.2B2.08×
New MMI Holdings, Inc.Series C$80.7M$1.8B1.77×
BioMatrix Holdings, L.L.C.Series C$80.0M$1.8B1.76×
Sea Hunter Holdings, LLCSeries C$76.3M$1.7B1.68×
Bind Benefits, Inc.Series C$70.0M$1.6B1.54×
Endotronix IncSeries C$116.1M$1.6B1.52×
Great Basin Scientific, Inc.Series C$124.3M$1.6B1.49×
TransMedics, Inc.Series C$249.0M$1.5B1.40×
Landmark Health, LLCSeries C$90.8M$1.4B1.34×
Rapid Micro Biosystems, Inc.Series C$134.6M$1.4B1.32×
Mdp Acm Holdings, LlcSeries C$60.0M$1.4B1.32×
ACON BioMatrix Investors I, L.L.C.Series C$57.5M$1.3B1.26×
OB Hospitalist Group, Inc. this companySeries C$73.8M$7.9M0.01×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$14.8M2010-04-09$67.5M$299.5M85%
Series C$50.6M2013-07-31$337.2M$1.2B85%
Series C$8.0M2014-07-02$53.3M$182.9M85%
Series C$344K2016-10-21$2.3M$7.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$14.8M2010-04-09
    • First recorded raise — entered as Series A.
    • 5 investors on this round.
  2. Series C$50.6M2013-07-31
    • Raised again after 40 mo — slower than the ~14 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • 1 investor on this round.
  3. Series C$8.0M2014-07-02
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 6.3× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 1 investor on this round.
  4. Series C$344K2016-10-21
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 23.3× smaller than the prior — bridge or down round.
    • 4 investors on this round.
Intelligence
2018 ~Q4
Modeled next raise · ~26mo cadence
$344K
Modeled next size est.range $344K$550K
0.0×
Last step-up
$11.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Bennett Rosenthal5 other2013-07
Joseph Clark4 other2016-10
Ravi Sarin2 other2013-07
Eric Reimer1 other2014-07
Lenny Castiglione1 other2016-10
Chris C. Crawford2010-04
Chris Pott2013-07
Chris Swain2013-07
Christopher C. Pott2010-04
Christopher C. Swain2010-04
Cliff Lawrence2013-07
David C. Swain2010-04
David Swain2013-07
Jackson C. Walker2010-04
Jon Cohen2016-10
Kevin Guion2013-07
Kevin Krenzke2016-10
Mark C. deLaar2010-04
Nav Rahemtulla2013-07
Registry & provenance

OB Hospitalist Group, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1489257
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
DMG Practice Management Solutions LLCHospitals and PhysiciansSeries C$99.8M$351.9Mnetwork1 shared operator · same stage
BVO Holdings, LLCOther Health CareSeries D+$335.8M$7.7Bnetwork1 shared operator · same sector
Emerald Coast Surgery Center L POther Health CareSeed$1.4M$1.0Mnetwork1 shared operator · same sector
Wilson Surgery Center, LLCOther Health CarePre-Seed$275K$431Knetwork1 shared operator · same sector
baebies inc.Other Health CareSeries B$92.8M$9.4Msame sector
Envoy Medical CorpOther Health CareSeries B$56.8M$6.7Msame sector
CLEARFLOW, IncOther Health CareSeries A$51.4M$6.8Msame sector
EB Holdings Corp.Other Health CareSeries D+$108.1M$9.2Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
OBGYN Physician Alliance, LLCOther Health CarePre-Seed$3.4M87%
Obstetrx, Inc.Other Health CareSeed$17.0M86%
PatientPing, Inc.Other Health CareSeries B$701.2M83%
Apnomed, Inc.Other Health CarePre-Seed$2.7M83%
BioMedx Group, Inc.Other Health CarePre-Seed$14.0M83%
DocAsap, Inc.Other Health CareSeries B$398.8M83%
Aging of America Group, Inc.Other Health CarePre-Seed$15.2M83%
Empirican Group Inc.Other Health CareSeries A$15.9M83%
Frequently asked
How much funding has OB Hospitalist Group, Inc. raised?
OB Hospitalist Group, Inc. has raised approximately $73.8M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is OB Hospitalist Group, Inc.'s estimated valuation?
Provath's modeled valuation for OB Hospitalist Group, Inc. is approximately $7.9M (modeled range $1.2M–$20.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is OB Hospitalist Group, Inc. at?
OB Hospitalist Group, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Oct 21.
What does OB Hospitalist Group, Inc. do and where is it based?
OB Hospitalist Group, Inc. operates in the Other Health Care sector, based in Mauldin.
Explore related

See where OB Hospitalist Group, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at OB Hospitalist Group, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.